You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

JB Chemicals soars after Q1 PAT spurts 92% to Rs 120 cr

Capital Market 

JB Chemicals & Pharmaceuticals soared 11.13% to Rs 922.45 after the company's consolidated net profit surged 92.4% to Rs 119.51 crore on 17.1% increase in net sales to Rs 522.29 crore in Q1 June 2020 over Q1 June 2019.

Consolidated profit before tax (PBT) soared 70.7% to Rs 157.07 crore in Q1 June 2020 as against Rs 91.99 crore in Q1 June 2019. Current tax expense for the quarter jumped 25.8% year-on-year to Rs 37.57 crore. The Q1 result was declared after market hours yesterday, 14 September 2020.

The business performance during the quarter improved due to a 18% growth in revenue coupled with an increase in other income (primarily from current investments) and a better product mix with savings in some heads of expenditure on account of the current situation due to the COVID-19 pandemic.

J B Chemicals & Pharmaceuticals is a pharmaceutical company manufacturing & marketing a diverse range of pharmaceutical formulations, herbal remedies and APIs.

The scrip hit an all-time high of Rs 965 in intraday trade. The stock has surged 186.74% from its 52-week low of Rs 321.70 hit on 24 October 2019.

On the technical front, the stock's RSI (relative strength index) stood at 80.628. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

The stock was trading above its 50-day moving average (DMA) placed at 757.42 and its 200-day moving average (DMA) placed at 601.52.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 15 2020. 10:52 IST